In veterinary medicine, doxycycline hyclate is a workhorse antibiotic for vector-borne diseases including canine ehrlichiosis, Lyme borreliosis, and bovine anaplasmosis. Its lipid-soluble hyclate salt ensures reliable absorption and extended tissue residence time, supporting once-daily dosing protocols in both production animals and companion species.
Quick Facts
| CAS Number | 24390-14-5 |
|---|---|
| Molecular Formula | C22H24N2O8 · HCl |
| Molecular Weight | 526.97 |
| HS Code | 2941302000 |
| Pharmacopoeia | BP/EP/CEP |
| Category | Veterinary API |
| Packaging | 25 KG/DRUM |
Product Overview
Doxycycline Hyclate is a broad-spectrum tetracycline antibiotic with exceptional tissue penetration and a long elimination half-life, making it one of the most widely used veterinary antibiotics worldwide. It demonstrates potent activity against respiratory pathogens, enteric bacteria, and vector-borne organisms including Rickettsia, Ehrlichia, and Anaplasma species.
Our Doxycycline Hyclate is CEP-certified, ensuring the highest pharmaceutical quality standards. The hyclate salt form provides excellent water solubility and bioavailability. Its lipid-soluble nature allows superior tissue distribution compared to older tetracyclines, achieving therapeutic concentrations in the respiratory tract, urogenital system, and CNS.
Quality Specifications
| Purity | As per BP/EP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |
Veterinary Applications
- Poultry: Chronic respiratory disease (CRD), Ornithobacterium rhinotracheale (ORT) infections
- Swine: Respiratory disease complex, bacterial pneumonia
- Cattle: Bovine anaplasmosis, respiratory infections
- Dogs: Canine ehrlichiosis and other tick-borne diseases
- Cats: Feline chlamydiosis and respiratory infections